Friday, December 16, 2016

BRIEF-MiMedx 2017 guidance forecasts revenue growth in excess of 21%, operating earnings growth in excess of 90%

* MiMedx 2017 guidance forecasts revenue growth in excess of

21% and operating earnings growth in excess of 90%

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)